Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 70
Filter
3.
5.
Clin Exp Dermatol ; 17(2): 94-8, 1992 Mar.
Article in English | MEDLINE | ID: mdl-1516249

ABSTRACT

This study compares the action spectra on two new patients with actinic reticuloid (AR), with one previously reported patient. All three patients had exquisite photosensitivity in the UVB range being up to 27 times more sensitive than controls. Sensitivity also increased into the UVA Range, all up to 335 nm and, one into the visible. Their photosensitivity made evaluation of the Sun Protection Factor (SPF) of selected, more recent, high-numbered sunscreens easier to compare, because of the shorter time of the minimal erythema dose when tested with a solar simulator. A sunscreen containing butyl methoxydibenzoylmethane (Parsol 1789) with an overall SPF of 16 was not as effective at protecting the actinic reticuloid patients as a higher SPF numbered sunscreen containing a benzophenone (SPF of 40). The Parsol 1789 gave a protection value of 5 in the UVA Range, compared to one of 3 given by the sunscreen containing benzophenone. The SPFs of seven of these commerically available high-numbered sunscreens were compared with controls.


Subject(s)
Photosensitivity Disorders/drug therapy , Sunscreening Agents/therapeutic use , Aged , Humans , Male , Middle Aged , Photosensitivity Disorders/etiology , Ultraviolet Rays/adverse effects
6.
J Am Acad Dermatol ; 26(2 Pt 1): 173-7, 1992 Feb.
Article in English | MEDLINE | ID: mdl-1552048

ABSTRACT

BACKGROUND: The safety of psoralen plus ultraviolet A (PUVA) light therapy has been an issue of debate. A few multiple-center cooperative studies have reported an increase of basal cell and squamous cell carcinomas among PUVA-treated patients. In our institute, more than 1000 patients have been treated with PUVA since 1975. OBJECTIVE: We investigated the incidence of skin cancer among patients who received high doses of PUVA to see whether such incidence increased. METHODS: This is a historical cohort study of two comparison groups of patients. Subjects under study were 492 psoriasis patients who received PUVA treatments between 1975 and 1989. One group of 103 patients, defined as the high-dose group, received an accumulated PUVA dose of 1000 joules/cm2 or more; another group of 389 patients, as the low-dose group, received 200 joules/cm2 or less. The occurrence of skin cancer in the two comparison groups is analyzed. RESULTS: In the high-dose group we observed an increased number of patients with squamous cell carcinoma, keratoacanthoma, and actinic keratosis. We did not see any patients with genital cancer, melanoma, or an increased number of patients with basal cell carcinoma. CONCLUSION: The risk of squamous cell carcinoma developing in patients who received a high dose of PUVA is confirmed. We speculate a combination of factors, including PUVA, may contribute to this risk.


Subject(s)
Carcinoma, Basal Cell/chemically induced , Carcinoma, Squamous Cell/chemically induced , PUVA Therapy/adverse effects , Psoriasis/drug therapy , Skin Neoplasms/chemically induced , Adult , Carcinoma, Basal Cell/epidemiology , Carcinoma, Squamous Cell/epidemiology , Cohort Studies , Dose-Response Relationship, Drug , Female , Follow-Up Studies , Humans , Incidence , Keratosis/chemically induced , Male , Middle Aged , Skin Neoplasms/epidemiology , Time Factors
7.
Radiogr Today ; 57(650): 17-22, 1991 Jul.
Article in English | MEDLINE | ID: mdl-1741942

ABSTRACT

The results of the survey show that macroradiography of the petrous temporal region is not a common practice. However, the results of the tests show that an increase in discernible detail can be achieved with only a slight increase in geometrical unsharpness, no loss in resolution and, if departmental protocol is to produce AP images through the magnified orbits, a reduction of over 100 times in the radiation exposure dose to the lens of the eye by producing PA macroradiographs instead. Taking into consideration both the image quality of the macro-radiographs obtained, and the radiation exposure dose received by the lens of the eye, the most suitable macroradiographic technique has been implemented within the department as a routine procedure.


Subject(s)
Petrous Bone/diagnostic imaging , Humans , Petrous Bone/anatomy & histology , Radiation Dosage , Radiography , Radiometry , Technology, Radiologic
9.
Int J Dermatol ; 28(7): 438-40, 1989 Sep.
Article in English | MEDLINE | ID: mdl-2777441

ABSTRACT

One hundred four psoriatic patients who had 8-methoxypsoralen-ultraviolet light A (PUVA) treatment between 1975-1987 were investigated to determine if skin cancer had ever occurred during or after the therapeutic period. Incidence data of skin cancer was applied to this group of patients to measure the expected number of patients with skin cancer. The significance of observed number versus expected of PUVA-treated patients with skin cancer was analyzed. The authors did not observe a significant increase of patients with skin cancer.


Subject(s)
PUVA Therapy/adverse effects , Skin Neoplasms/chemically induced , Adult , Aged , Female , Follow-Up Studies , Humans , Male , Middle Aged , Psoriasis/drug therapy , Time Factors
10.
Biomed Environ Sci ; 2(1): 36-43, 1989 Mar.
Article in English | MEDLINE | ID: mdl-2590490

ABSTRACT

During the period 1955-1959, approximately 4000 people in southeast Anatolia developed porphyria due to the ingestion of hexachlorobenzene (HCB), a fungicide added to wheat seedlings. These HCB exposures subsequently led to the development of bullae on sun-exposed areas, hyperpigmentation, hypertrichosis, and porphyrinuria. The condition was called kara yara or "black sore." Many of the breast-fed children under the age of 2 years whose mothers had ingested HCB-treated grain died from a disease known as pembe yara or "pink sore." In this follow-up study of 252 patients, 20-30 years postexposure, there were 162 males and 90 females, with an average current age of 35.7 years, an average of onset of 7.6 years, and a duration of 2.2 years. Many patients had dermatologic, neurologic, and orthopedic symptoms and signs. The observed clinical findings include scarring of the face and hands (83.7%), hyperpigmentation (65%), hypertrichosis (44.8%), pinched facies (40.1%), painless arthritis (70.2%), small hands (66.6%), sensory shading (60.6%), myotonia (37.9%), cogwheeling (41.9%), enlarged thyroid (34.9%), and enlarged liver (4.8%). Urine and stool porphyrin levels were determined in all patients, and 17 have at least one of the porphyrins elevated. A total of 56 specimens of human milk obtained from mothers with porphyria were analyzed for HCB. The average value was 0.51 ppm in HCB-exposed patients compared to 0.07 ppm in unexposed controls. Offspring of mothers with three decades of HCB-induced porphyria appear normal.


Subject(s)
Chlorobenzenes/poisoning , Hexachlorobenzene/poisoning , Porphyrias/chemically induced , Adolescent , Child , Child, Preschool , Disease Outbreaks , Feces/analysis , Female , Follow-Up Studies , Hexachlorobenzene/analysis , Humans , Infant , Male , Milk, Human/analysis , Porphyrias/epidemiology , Porphyrias/metabolism , Porphyrins/analysis , Porphyrins/urine , Skin Diseases/chemically induced , Skin Diseases/epidemiology , Skin Diseases/metabolism , Turkey/epidemiology
11.
J Am Acad Dermatol ; 17(2 Pt 2): 332-8, 1987 Aug.
Article in English | MEDLINE | ID: mdl-3624576

ABSTRACT

Rothmund-Thomson syndrome is a rare hereditary syndrome with developmental defects. Characteristics of this syndrome, based on a review of 107 reported cases in the literature, are (in descending order) as follows: early onset of poikiloderma, short stature, absence or sparseness of eyebrow and/or eyelash hair, familial juvenile cataracts, small hands and bone defects, sunlight sensitivity, hypogonadism, defective dentition, nail abnormality, hyperkeratosis, and mental retardation. Recently we encountered a 25-year-old white woman who had developed this syndrome but without juvenile cataracts, hypogonadism, or mental retardation. She had developed a basal cell epithelioma, which has not previously been described in this syndrome. Phototesting with monochromatic radiation and with a solar simulator showed photosensitivity in the ultraviolet A range but not in the ultraviolet B range. This case may represent an example of the Thomson type. The case is described and the literature reviewed.


Subject(s)
Abnormalities, Multiple , Cataract , Photosensitivity Disorders , Rothmund-Thomson Syndrome , Skin Diseases , Adult , Bone and Bones/abnormalities , Diagnosis, Differential , Female , Humans , Photosensitivity Disorders/diagnosis , Rothmund-Thomson Syndrome/diagnosis , Rothmund-Thomson Syndrome/pathology , Skin Diseases/diagnosis , Skin Diseases/pathology , Syndrome
12.
Fed Proc ; 46(5): 1894-900, 1987 Apr.
Article in English | MEDLINE | ID: mdl-3556614

ABSTRACT

Porphyria cutanea tarda (PCT) is the most frequently reported type of porphyria. The average patient is male more than 40 years old with a history of alcohol consumption. In women the incidence of PCT has increased with use of estrogens for birth control. The cutaneous features are those of chronic porphyrin photosensitivity on the light-exposed area of the skin: pigmentation, hirsuitism and fragility, and vesiculobullae, which has prompted the expression bullosa actinica et mechanica. One-third of the patients have glucose intolerance. PCT has been reported frequently among the Bantu people in South Africa as resulting from combinations of alcohol and cooking in ironware. The average patient has a higher than normal hematocrit, which is used as a guide to treatment by phlebotomy ranging from 8 to 14 units removed every 2-4 wk. Chemically induced PCT has been reported with chlorinated hydrocarbons, the best-known of which is hexachlorobenzene (HCB). Porphyria was noted in more than 3,000 patients in southeast Turkey between 1955 and 1961, because of consumption of seed wheat treated with HCB. In addition, more than 1,000 children under the age of 1 year died because HCB was transferred from the mother, either via the placenta or through breast milk.


Subject(s)
Alcohol Drinking , Diet , Liver Diseases/metabolism , Porphyrias/metabolism , Skin Diseases/metabolism , Bloodletting , Diabetes Mellitus/etiology , Diet/adverse effects , Hexachlorobenzene/adverse effects , Humans , Iron/metabolism , Porphyrias/complications , Porphyrias/etiology , Porphyrias/therapy , Porphyrins/metabolism , Skin Diseases/therapy , Turkey
15.
J Am Acad Dermatol ; 14(2 Pt 1): 183-6, 1986 Feb.
Article in English | MEDLINE | ID: mdl-2936772

ABSTRACT

The efficacy of erythromycin base (E-Mycin tablets, 333 mg) and the efficacy of tetracycline hydrochloride (Panmycin tablets) were compared in this double-blind, randomized study. Two hundred patients with moderate to moderately severe acne vulgaris were randomly assigned to the study. One hundred patients received 1 gm of erythromycin base by mouth per day for 4 weeks, followed by 333 mg/day for 8 weeks, plus placebo for tetracycline. The second group of patients received 1 gm of tetracycline by mouth per day for 4 weeks, followed by 500 mg/day for 8 weeks, plus placebo for erythromycin. Both drugs reduced acne severity to the same extent. Pustules, papules, and open comedo counts decreased significantly over the 12-week period. Seventy-seven percent of the erythromycin-treated patients and 89% of the tetracycline-treated patients stated that their acne was markedly improved or improved by week 12. Most of the side effects in patients treated with erythromycin were gastrointestinal symptoms. Among the side effects in patients treated with tetracycline were Candida vaginitis in one patient and pseudotumor cerebri in one patient.


Subject(s)
Acne Vulgaris/drug therapy , Erythromycin/therapeutic use , Tetracycline/therapeutic use , Administration, Oral , Adolescent , Adult , Clinical Trials as Topic , Diarrhea/chemically induced , Double-Blind Method , Erythromycin/administration & dosage , Erythromycin/adverse effects , Female , Humans , Nausea/chemically induced , Pregnancy , Tetracycline/administration & dosage , Tetracycline/adverse effects
18.
IARC Sci Publ ; (77): 417-23, 1986.
Article in English | MEDLINE | ID: mdl-3596733

ABSTRACT

Subchronic and chronic toxicities of hexachlorobenzene (HCB) were studied in both sexes of Swiss mice, Syrian golden hamsters and Sprague-Dawley rats, at dietary dosages of 0, 100 and 200 ppm (mice), and 0, 200 and 400 ppm (hamsters and rats) for 90 days. At day 91, 25/50 animals in each of 18 groups were killed for histology studies. The rest were killed at 6-week intervals until the study was ended. Marked hepatosplenomegaly, enlarged thymuses and lymph nodes, or swollen and granular-looking renal cortices with depressions or nodulary areas were commonly observed. Dose- and sex-dependent progressive changes included toxic-degenerative hepatitis, chronic cirrhosis, hepatomas, bile-duct adenomas and a few hepatocarcinomas in older animals. A generalized lymphohaematopoietic response led to thymic, splenic and nodal lymphosarcomas, especially in female mice. Toxic-tubular nephritis with cortical infarcts developed into regenerative foci and renal adenomas in low incidences. Liver lesions were more prominent in females, while renal changes were most common in male rats. HCB was retested in both sexes of rats at oral doses of 0, 75 and 150 ppm for up to 2 years. At the start, each group contained 94 rats, and four randomly selected rats were killed at weeks 0, 1, 2, 3, 4, 8, 16, 32, 48 and 64 for microscopy. Progressive liver lesions started as hyperaemia and degenerations (4 weeks), and developed into toxic hepatitis, cirrhosis and formation of pre- and neoplastic foci (36 weeks), with hepatomas, bile-duct adenomas and hepatocellular carcinomas (64 weeks) in very high incidences in females and renal adenomas in male rats.


Subject(s)
Chlorobenzenes/toxicity , Hexachlorobenzene/toxicity , Neoplasms, Experimental/chemically induced , Animals , Cricetinae , Female , Kidney/drug effects , Liver/drug effects , Male , Mesocricetus , Mice , Rats , Rats, Inbred Strains , Sex Factors
19.
IARC Sci Publ ; (77): 567-73, 1986.
Article in English | MEDLINE | ID: mdl-3596756

ABSTRACT

It has been estimated that during 1955-1959 in southeastern Turkey, approximately 4000 people developed porphyria due to ingestion of hexachlorobenzene (HCB), a fungicide added to wheat seedlings. Patients subsequently developed bullae on sun-exposed areas, hyperpigmentation, hirsutism, weakness and porphyrinuria. Children born to mothers who had ingested the grain were exposed to HCB in maternal milk and transplacentally, resulting in the death of children under the age of two. In this follow-up study, 204 patients with a past history of HCB-induced porphyria were re-evaluated. There were 132 males and 72 females, with an average age of 32.1 years, an average age of onset of 7.1 years and a duration of 2.4 years. The clinical features of the 204 patients were: scarring of the face and hands in 86.7%, hyperpigmentation in 71.1%, hirsutism in 47.1%, pinched facies in 41.2%, fragile skin in 37.7%, painless arthritis in 66.6%, small hands in 64.2%, an enlarged liver in 4.4% and an enlarged thyroid in 37.3%; most patients also showed neurological symptoms. Urine and stool porphyrin levels were determined in all patients. Seventeen showed elevated levels of one of the porphyrins and eight were considered still porphyric after 25-30 years. A total of 56 specimens of human milk obtained from porphyric mothers were analysed for HCB. The average value was 0.51 ppm compared with 0.07 in controls. After HCB ingestion, abnormal porphyrin metabolism, dermatological, orthopaedic and neurological findings, and HCB residues in the milk of porphyric patients have been shown to persist at least for 25-30 years.


Subject(s)
Chlorobenzenes/toxicity , Hexachlorobenzene/toxicity , Porphyrias/chemically induced , Adult , Female , Hexachlorobenzene/analysis , Humans , Male , Middle Aged , Milk, Human/analysis , Porphyrins/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...